Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Communications Medicine
|
May 23, 2026
Aminoglycosides induce immune activation but is insufficient for systemic viral control: a double-blind randomized-controlled clinical trial
Punitha Sivanandam, Ayesa Syenina, Yvonne Fz Chan, et al.
Plos Pathogens
|
April 5, 2014
First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies
Jowin Kai Wei Ng, Summer Lixin Zhang, Hwee Cheng Tan, et al.
Ebiomedicine
|
October 12, 2020
Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection
Clement Yau, Esther Shuyi Gan, Swee Sen Kwek, et al.
Plos Neglected Tropical Diseases
|
February 10, 2018
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
Yadunanda Budigi, Eugenia Z Ong, Luke N Robinson, et al.
Msphere
|
September 20, 2019
Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection
Candice Y Y Chan, John Zhong Heng Low, Esther Shuyi Gan, et al.
Plos One
|
April 18, 2012
A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein
Annie Hoi Yi Chan, Hwee Cheng Tan, Angelia Yee Chow, et al.
Cell Host & Microbe
|
November 3, 2019
Persistent Dengue Infection in an Immunosuppressed Patient Reveals the Roles of Humoral and Cellular Immune Responses in Virus Clearance
Kar-Hui Ng, Summer Lixin Zhang, Hwee Cheng Tan, et al.
Science (New York, N.Y.)
|
July 4, 2015
Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness
Gayathri Manokaran, Esteban Finol, Chunling Wang, et al.
Vaccine
|
March 25, 2026
Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humans
Justin S G Ooi, Noor Zayanah Hamis, Hwee Cheng Tan, et al.
Cell Reports
|
May 14, 2020
A Non-structural 1 Protein G53D Substitution Attenuates a Clinically Tested Live Dengue Vaccine
Milly M Choy, Dorothy H L Ng, Tanamas Siriphanitchakorn, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Communications Medicine
|
May 23, 2026
Aminoglycosides induce immune activation but is insufficient for systemic viral control: a double-blind randomized-controlled clinical trial
Punitha Sivanandam, Ayesa Syenina, Yvonne Fz Chan, et al.
Plos Pathogens
|
April 5, 2014
First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies
Jowin Kai Wei Ng, Summer Lixin Zhang, Hwee Cheng Tan, et al.
Ebiomedicine
|
October 12, 2020
Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection
Clement Yau, Esther Shuyi Gan, Swee Sen Kwek, et al.
Plos Neglected Tropical Diseases
|
February 10, 2018
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
Yadunanda Budigi, Eugenia Z Ong, Luke N Robinson, et al.
Msphere
|
September 20, 2019
Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection
Candice Y Y Chan, John Zhong Heng Low, Esther Shuyi Gan, et al.
Plos One
|
April 18, 2012
A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein
Annie Hoi Yi Chan, Hwee Cheng Tan, Angelia Yee Chow, et al.
Cell Host & Microbe
|
November 3, 2019
Persistent Dengue Infection in an Immunosuppressed Patient Reveals the Roles of Humoral and Cellular Immune Responses in Virus Clearance
Kar-Hui Ng, Summer Lixin Zhang, Hwee Cheng Tan, et al.
Science (New York, N.Y.)
|
July 4, 2015
Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness
Gayathri Manokaran, Esteban Finol, Chunling Wang, et al.
Vaccine
|
March 25, 2026
Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humans
Justin S G Ooi, Noor Zayanah Hamis, Hwee Cheng Tan, et al.
Cell Reports
|
May 14, 2020
A Non-structural 1 Protein G53D Substitution Attenuates a Clinically Tested Live Dengue Vaccine
Milly M Choy, Dorothy H L Ng, Tanamas Siriphanitchakorn, et al.
Page
of 6